aid: treadwell-therapeutics
name: Treadwell Therapeutics
description: >-
  Treadwell Therapeutics is a clinical-stage, multi-modality oncology company developing novel small-molecule
  therapeutics for highly aggressive cancers by targeting tumor-specific vulnerabilities such as aneuploidy and
  immunogenicity. Co-founded by Tak Wah Mak, PhD and Mark R. Bray, PhD, the company keeps drug discovery and
  clinical development under one roof and works out of Toronto (with a research footprint at the University Health
  Network), New York and Hong Kong. Its internally developed pipeline includes CFI-400945, an oral PLK4 inhibitor in
  Phase 1/2 studies across triple-negative breast cancer, prostate cancer and acute myeloid leukemia (FDA Fast Track
  designation); CFI-402257, a TTK inhibitor in Phase 1b/2; and CFI-402411, a first-in-class HPK1 inhibitor. Treadwell
  is a therapeutics developer, not a software vendor - it publishes no developer program, no public API, and no
  machine-readable API contract. Profiled by API Evangelist from its own public corporate site.
image: https://treadwelltx.com/wp-content/uploads/logo.png
url: https://raw.githubusercontent.com/api-evangelist/treadwell-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-30'
modified: '2026-08-30'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Life Sciences
- Healthcare
- Clinical Trials
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/treadwell-therapeutics-domain-security.yml
- type: Website
  url: https://treadwelltx.com/
- type: Blog
  url: https://treadwelltx.com/news/
- type: BlogRSS
  url: https://treadwelltx.com/feed/
- type: TermsOfService
  url: https://treadwelltx.com/terms-of-use/
- type: LLMsTxt
  url: llms/treadwell-therapeutics-llms.txt
- type: Plans
  url: plans/treadwell-therapeutics-plans-pricing.yml
- type: RateLimits
  url: rate-limits/treadwell-therapeutics-rate-limits.yml
x-enrichment:
  date: '2026-08-30'
  status: minimal
  artifacts_added: 6
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Treadwell Therapeutics is a privately held clinical-stage oncology drug developer whose entire web
    presence is an eight-page WordPress marketing site on Flywheel - the only machine-readable things
    it serves are an SEO-plugin llms.txt and the WordPress core wp-json CMS index, and every
    OpenAPI/Swagger/GraphQL/.well-known path returns the site's WordPress 404 template.
  evidence:
  - url: https://treadwelltx.com/openapi.json
    status: 404
  - url: https://treadwelltx.com/graphql
    status: 404
  - url: https://treadwelltx.com/.well-known/api-catalog
    status: 404
  - url: https://treadwelltx.com/.well-known/agent-card.json
    status: 404
  - url: https://treadwelltx.com/llms.txt
    status: 200
  - url: https://treadwelltx.com/wp-json/
    status: 200
  checked: '2026-08-30'